Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

The potential of 1,8-DIMERCAPT0-3,6-DIOXAOCTANE (DMDO to induce delayed contact hypersensitivity was evaluated in guinea-pigs according to the maximization method of Magnusson and Kligman and to O.E.C.D. (No. 406, l 7th July 1992) and E.C. (92/69/E.E.C., B6, 31st July 1992) guidelines (Manciaux, 1998). The study was conducted in compliance with the Principles of Good Laboratory Practice Regulations. Thirty guinea-pigs were allocated to two groups: a control group 1 (five males and five females) and a treated group 2 (ten males and ten females). On day 1, intradermal injections of Freund's complete adjuvant mixed with the test substance (treated group) or the vehicle (control group) were performed in the interscapular region. On day 8, this same test site received a cutaneous application of the test substance (treated group) or the vehicle (control group) and was then covered by an occlusive dressing for 48 hours. On day 22, after a rest period of 12 days, all animals of the treated and control groups were challenged by a cutaneous application of the test substance to the right flank. The left flank served as control and received the vehicle only. Test substance and vehicle were maintained under an occlusive dressing for 24 hours. Skin reactions were evaluated approximately 24 and 48 hours after removal of the dressing.

Test substance concentrations were as follows:

Induction (treated group):

. intradermal injections: DMDO at the concentration of 5% (w/w) in paraffin oil

. topical application: DMDO undiluted.

Challenge (all groups):

. topical application: DMDO at the concentration of 10% (w/w) in paraffin oil.

At the end of the study, animals were killed without examination of internal organs. No skin samples were taken from the challenge application sites. The sensitivity of the guinea-pigs was checked with positive sensitizers DNCB and MERCAPTOBENZOTHIAZOLE.

No clinical signs and no deaths were noted during the study. No cutaneous reactions were observed after the challenge application. The species and strain which were used showed a satisfactory sensitization response in 90% animals treated with DNCB and in 30% animals treated with MERCAPTOBENZOTHIAZOLE. DMDO does not induce delayed contact hypersensitivity in guinea-pigs.

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records
Reference
Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Version / remarks:
1992
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
Study performed before the implementation of the REACH regulation
Species:
guinea pig
Strain:
Dunkin-Hartley
Sex:
male/female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Charles River France, 76410 Saint-Aubin-lès-Elbeuf, France
- Females nulliparous and non-pregnant: yes
- Microbiological status of animals, when known:
- Age at study initiation: approximately three months old
- Weight at study initiation: 354 ± 11 g for the males and 335 ± 15 g for the females
- Housing: individually in polycarbonate cages
- Diet: "106 pelleted diet" (U.A.R., 91360 Villemoisson-sur-Orge, France), ad libitum
- Water: water filtered by a F.G. Millipore membrane (0.22 micron), ad libitum
- Acclimation period: at least 5 days
- Indication of any skin lesions: none

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21±2
- Humidity (%): 30 to 70
- Air changes (per hr): 12 cycles/hour of filtered, non-recycled air
- Photoperiod (hrs dark / hrs light): 12/12
Route:
intradermal
Vehicle:
paraffin oil
Concentration / amount:
5 %
Day(s)/duration:
Day 1
Adequacy of induction:
highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
Route:
epicutaneous, occlusive
Vehicle:
unchanged (no vehicle)
Concentration / amount:
100 %
Day(s)/duration:
Day 8
Adequacy of induction:
non-irritant substance, but skin pre-treated with 10% SDS
Route:
epicutaneous, occlusive
Vehicle:
paraffin oil
Concentration / amount:
10 %
Day(s)/duration:
Day 22
Adequacy of challenge:
highest non-irritant concentration
No. of animals per dose:
10
Details on study design:
On day 1, intradermal injections of Freund's complete adjuvant mixed with the test substance (treated group) or the vehicle (control group) were performed in the interscapular region.
On day 8, this same test site received a cutaneous application of the test substance (treated group) or the vehicle (control group) and was then covered by an occlusive dressing for 48 hours.
On day 22, after a rest period of 12 days, ail animais of the treated and control groups were challenged by a cutaneous application of the test substance to the right flank. The left flank served as control and received the vehicle only. Test substance and vehicle were maintained under an occlusive dressing for 24 hours.
Skin reactions were evaluated approximately 24 and 48 hours after removal of the dressing.
Test substance concentrations were as follows:
Induction (treated group)
intradermal injections: 1,8-DIMERCAPT0-3,6-DIOXAOCTANE at the concentration of 5% (w/w) in paraffin oil
. topical application: l,8-DIMERCAPT0-3,6-DIOXAOCTANE undiluted.
Challenge (all groups)
topical application: 1,8-DIMERCAPT0-3,6-DIOXAOCT ANE at the concentration of 10% (w/w) in paraffin oil
At the end of the study, animais were killed without examination of internai organs.
No skin samples were taken from the challenge application sites.
Challenge controls:
left flank: vehicle
right flank: test substance at the concentration of 10 % (w/w)
Positive control substance(s):
yes
Remarks:
DNCB and MERCAPTOBENZOTHIAZOLE
Positive control results:
The species and strain which were used showed a satisfactory sensitization response in 90% animais treated with DNCB and in 30% animais treated with MERCAPTOBENZOTHIAZOLE.
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
10%
No. with + reactions:
0
Total no. in group:
10
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
10%
No. with + reactions:
0
Total no. in group:
10
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
10%
No. with + reactions:
0
Total no. in group:
20
Remarks on result:
no indication of skin sensitisation
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
10%
No. with + reactions:
0
Total no. in group:
20
Remarks on result:
no indication of skin sensitisation
Interpretation of results:
GHS criteria not met
Conclusions:
1,8-DIMERCAPT0-3,6-DIOXAOCTANE does not induce delayed contact hypersensitivity in guinea-pigs.
Executive summary:

The potential of 1,8-DIMERCAPT0-3,6-DIOXAOCTANE to induce delayed contact hypersensitivity was evaluated in guinea-pigs according to the maximization method of Magnusson and Kligman and to O.E.C.D. (No. 406, l 7th July 1992) and E.C. (92/69/E.E.C., B6, 31st July 1992) guidelines. The study was conducted in compliance with the Principles of Good Laboratory Practice Regulations. Thirty guinea-pigs were allocated to two groups: a control group 1 (five males and five females) and a treated group 2 (ten males and ten females). On day 1, intradermal injections of Freund's complete adjuvant mixed with the test substance (treated group) or the vehicle (control group) were performed in the interscapular region. On day 8, this same test site received a cutaneous application of the test substance (treated group) or the vehicle (control group) and was then covered by an occlusive dressing for 48 hours. On day 22, after a rest period of 12 days, all animals of the treated and control groups were challenged by a cutaneous application of the test substance to the right flank. The left flank served as control and received the vehicle only. Test substance and vehicle were maintained under an occlusive dressing for 24 hours. Skin reactions were evaluated approximately 24 and 48 hours after removal of the dressing.

Test substance concentrations were as follows:

Induction (treated group):

. intradermal injections: 1,8-DIMERCAPT0-3,6-DIOXAOCTANE at the concentration of 5% (w/w) in paraffin oil

. topical application: l,8-DIMERCAPT0-3,6-DIOXAOCTANE undiluted.

Challenge (all groups):

. topical application: 1,8-DIMERCAPT0-3,6-DIOXAOCTANE at the concentration of 10% (w/w) in paraffin oil.

At the end of the study, animals were killed without examination of internal organs. No skin samples were taken from the challenge application sites. The sensitivity of the guinea-pigs was checked with positive sensitizers DNCB and MERCAPTOBENZOTHIAZOLE.

No clinical signs and no deaths were noted during the study. No cutaneous reactions were observed after the challenge application. The species and strain which were used showed a satisfactory sensitization response in 90% animals treated with DNCB and in 30% animals treated with MERCAPTOBENZOTHIAZOLE. 1,8-DIMERCAPT0-3,6-DIOXAOCTANE does not induce delayed contact hypersensitivity in guinea-pigs.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

Not classified according to CLP criteria.